Infinity Pharmaceuticals, Inc. (INFIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST
Infinity Pharmaceuticals Revenue
Infinity Pharmaceuticals had revenue of $583.00K in the quarter ending June 30, 2023, a decrease of -15.01%. This brings the company's revenue in the last twelve months to $2.57M, up 15.88% year-over-year. In the year 2022, Infinity Pharmaceuticals had annual revenue of $2.59M with 39.56% growth.
Revenue (ttm)
2.57M
Revenue Growth
+15.88%
P/S Ratio
0.00
Revenue / Employee
85.63K
Employees
30
Market Cap
91.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 2.59M | 735.00K | 39.56% |
| Dec 31, 2021 | 1.86M | 139.00K | 8.09% |
| Dec 31, 2020 | 1.72M | -1.33M | -43.62% |
| Dec 31, 2019 | 3.05M | -19.10M | -86.23% |
| Dec 31, 2018 | 22.15M | 16.15M | 269.10% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oriental Bioengineering | 121.58M |
| RVL Pharmaceuticals | 36.92M |
| Cardax | 500.71K |
| Notable Labs | 313.00K |
| Bioasis Technologies | 199.01K |
| Marizyme | 183.42K |
| Athersys | 80.00K |
| Navidea Biopharmaceuticals | 610.00 |